Zymeworks (ZYME) Return on Sales (2021 - 2026)

Zymeworks (ZYME) has 6 years of Return on Sales data on file, last reported at 0.18% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales fell 18.0% year-over-year to 0.18%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), and the FY2025 full-year result was 0.01%, up 1.0% from the prior year.
• Return on Sales slipped to 0.18% in Q1 2026, from 0.16% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2022 to a low of 0.38% in Q1 2022.
• A 5-year average of 0.07% and a median of 0.02% in 2024 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales soared 37 bps in 2023 and dropped 18 bps in 2026, its largest moves.
• Tracing ZYME's Return on Sales over 5 years: stood at 0.01% in 2022, then plunged by 190 bps to 0.01% in 2023, then rose by 11 bps to 0.01% in 2024, then tumbled by 2063 bps to 0.16% in 2025, then dropped by 12 bps to 0.18% in 2026.
• Business Quant data shows ZYME's Return on Sales at 0.18% in Q1 2026, 0.16% in Q4 2025, and 0.01% in Q3 2025.